MESO
Mesoblast Limited
NASDAQ · AUHealthcareBiotechnology
$16.63-3.98%
Price as of Jul 20, 2026
MESO valuation
Mesoblast Limited valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 60.55x
- P/E 2028E
- 16.86x
- P/S forward
- 140.88x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.74x
- Price / sales
- 32.88x
- Price / cash flow
- -37.20x
Enterprise value
- Enterprise value
- $2.2B
- EV / sales
- 32.97x
- EV / EBITDA
- -33.50x
- EV / EBIT
- -14.78x
- Market cap
- $2.1B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.